Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1320
Selected: 0
NCT IDTitle
NCT00165204Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy
NCT00788775Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma
NCT03020030Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
NCT03070236PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions
NCT03833934Study of Plasma NGS for Assessment, Characterization, Evaluation of Patients With ALK Resistance
NCT00134706A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer
NCT00809367Collection and Banking of Leukemia Cells MDS/AML
NCT00684411Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma
NCT01853345iCAT for Recurrent/Refractory/HR Solid Tumors
NCT03999684A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma
NCT01196936Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors
NCT02912572Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer
NCT05608252VS-6766+Abema+Fulv in Met HR+/HER- BC
NCT00548236The Active After Cancer Trial (AACT)
NCT00207636Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening
NCT04624633Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL
NCT02195232Cancer Associated Thrombosis and Isoquercetin (CATIQ)
NCT06888089Deep Clinical Trajectory Modeling to Optimize Accrual to Cancer Clinical Trials
NCT00369226Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation
NCT07548476Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy
NCT02171078Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance
NCT04634435Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients
NCT04758403CBCT-Guided Navigational Bronchoscopy For Lung Nodules
NCT01878708A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma
NCT02133625A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors
NCT02326974T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA
NCT07412041Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study
NCT03364673Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian Cancer
NCT04339062Cemiplimab in AlloSCT/SOT Recipients With CSCC
NCT02248662Impact of Radiation Therapy on Breast Conservation in DCIS
NCT01476462Second Malignant Neoplasms After Childhood ALL Therapy
NCT01808417NIR-Guided Sentinel Lymph-Node Mapping for Esophageal Cancer
NCT01400685Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLL
NCT06692452Tazemetostat Plus CHOP in 1L T-cell Lymphoma
NCT07434843PH 2 Pemigatinib in SDH-deficient GIST
NCT06831552Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
NCT02203825Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands
NCT00251355Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer
NCT05521178Cardiotoxicities in Patients Receiving BTKi
NCT06468618Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients
NCT03152318A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
NCT00782626Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas
NCT01002248Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients
NCT00529035Ultra-Low Dose Interleukin-2 for Refractory Chronic Graft Versus Host Disease
NCT01188876Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer
NCT00137852Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer
NCT02666378Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer
NCT04379414YES Study - Newly Diagnosed/Metastatic Intervention
NCT03740334Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
NCT00133367Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus